{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:33:04Z","timestamp":1783661584534,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20POST35211127"],"award-info":[{"award-number":["20POST35211127"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["MSCRF-3688"],"award-info":[{"award-number":["MSCRF-3688"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL149926"],"award-info":[{"award-number":["1R01HL149926"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.yjmcc.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T23:41:02Z","timestamp":1666222862000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8"],"prefix":"10.1016","volume":"173","author":[{"given":"Moradeke A.","family":"Bamgboye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Traficante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Owoyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"DiSilvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana C.O.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy E.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2022.10.003_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1196\/annals.1341.008","article-title":"Calcium signaling in cardiac ventricular myocytes","volume":"1047","author":"Bers","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.yjmcc.2022.10.003_bb0010","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/europace\/euu063","article-title":"Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes","volume":"16","author":"Fukuyama","year":"2014","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.yjmcc.2022.10.003_bb0020","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1073\/pnas.0502506102","article-title":"Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations","volume":"102","author":"Splawski","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCEP.113.000092","article-title":"Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome","volume":"6","author":"Gao","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2022.10.003_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hrthm.2006.04.024","article-title":"Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8)","volume":"3","author":"Jacobs","year":"2006","journal-title":"Heart Rhythm."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0035","first-page":"e62","article-title":"Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8)","volume":"35","author":"Shah","year":"2010","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2350-15-48","article-title":"Exome sequencing helped the fine diagnosis of two siblings afflicted with atypical Timothy syndrome (TS2)","volume":"15","author":"Frohler","year":"2014","journal-title":"BMC Med. Genet."},{"issue":"8","key":"10.1016\/j.yjmcc.2022.10.003_bb0045","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/mp.2013.107","article-title":"A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain","volume":"19","author":"Gershon","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0050","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1038\/ncomms10370","article-title":"Arrhythmogenesis in Timothy syndrome is associated with defects in Ca(2+)-dependent inactivation","volume":"7","author":"Dick","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.yjmcc.2022.10.003_bb0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00424-020-02430-0","article-title":"Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome","volume":"472","author":"Marcantoni","year":"2020","journal-title":"Pflugers Arch."},{"issue":"11","key":"10.1016\/j.yjmcc.2022.10.003_bb0060","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213209","article-title":"CaV1.2 channelopathic mutations evoke diverse pathophysiological mechanisms","volume":"154","author":"Bamgboye","year":"2022","journal-title":"J. Gen. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.04.018","article-title":"Novel therapeutics for treatment of long-QT syndrome and torsade de pointes","volume":"95","author":"Khan","year":"2004","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2022.10.003_bb0070","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/anie.202011793","article-title":"Structural basis of the modulation of the voltage-gated calcium ion channel Cav 1.1 by dihydropyridine compounds*","volume":"60","author":"Gao","year":"2021","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"2","key":"10.1016\/j.yjmcc.2022.10.003_bb0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuron.2007.11.036","article-title":"Regulation of presynaptic ca(V)2.1 channels by Ca2+ sensor proteins mediates short-term synaptic plasticity","volume":"57","author":"Mochida","year":"2008","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.yjmcc.2022.10.003_bb0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1124\/mol.119.117531","article-title":"Structural basis for diltiazem block of a voltage-gated ca(2+) channel","volume":"96","author":"Tang","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pcad.2004.04.006","article-title":"Calcium antagonists","volume":"47","author":"Grossman","year":"2004","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.yjmcc.2022.10.003_bb0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1524-6175.2004.03683.x","article-title":"The role of existing and newer calcium channel blockers in the treatment of hypertension","volume":"6","author":"Basile","year":"2004","journal-title":"J. Clin. Hypertens (Greenwich)"},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2022.10.003_bb0100","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0026-895X(25)09574-4","article-title":"Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines","volume":"50","author":"Johnson","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yjmcc.2022.10.003_bb0105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0021-9258(18)46015-2","article-title":"Cloning and expression of a cardiac\/brain beta subunit of the L- type calcium channel","volume":"267","author":"Perez-Reyes","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.yjmcc.2022.10.003_bb0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1113\/jphysiol.1997.sp021956","article-title":"Bursts of action potential waveforms relieve G-protein inhibition of recombinant P\/Q-type Ca2+ channels in HEK 293 cells","volume":"499","author":"Brody","year":"1997","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2022.10.003_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44161-022-00060-6","article-title":"Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium current","volume":"1","author":"Chakouri","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.stemcr.2017.05.028","article-title":"Inhibition of CDK5 alleviates the cardiac phenotypes in Timothy syndrome","volume":"9","author":"Song","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCRESAHA.116.309283","article-title":"A precision medicine approach to the rescue of function on malignant calmodulinopathic long-QT syndrome","volume":"120","author":"Limpitikul","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2022.10.003_bb0135","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O\u2019Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0140","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.RES.55.3.336","article-title":"Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists","volume":"55","author":"Sanguinetti","year":"1984","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.yjmcc.2022.10.003_bb0145","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1073\/pnas.94.24.13323","article-title":"Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation","volume":"94","author":"Hering","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yjmcc.2022.10.003_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-2828(83)90291-2","article-title":"Diltiazem and verapamil preferentially block inactivated cardiac calcium channels","volume":"15","author":"Kanaya","year":"1983","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5911","key":"10.1016\/j.yjmcc.2022.10.003_bb0155","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/302790a0","article-title":"Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells","volume":"302","author":"Lee","year":"1983","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.yjmcc.2022.10.003_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2012.04.029","article-title":"Two mechanistically distinct effects of dihydropyridine nifedipine on CaV1.2 L-type Ca(2)(+) channels revealed by Timothy syndrome mutation","volume":"685","author":"Sheng","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"7618","key":"10.1016\/j.yjmcc.2022.10.003_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated ca(2+) channel by Ca(2+) antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.yjmcc.2022.10.003_bb0170","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.1073\/pnas.94.25.14042","article-title":"beta subunits influence the biophysical and pharmacological differences between P- and Q-type calcium currents expressed in a mammalian cell line","volume":"94","author":"Moreno","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12265-012-9444-x","article-title":"Modeling Timothy syndrome with iPS cells","volume":"6","author":"Yazawa","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yjmcc.2014.04.022","article-title":"Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes","volume":"74","author":"Limpitikul","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2022.10.003_bb0185","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/CIRCULATIONAHA.112.001216","article-title":"Calmodulin mutations associated with recurrent cardiac arrest in infants","volume":"127","author":"Crotti","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220568","article-title":"Treatment of calmodulinopathy with verapamil","volume":"2017","author":"Webster","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.yjmcc.2022.10.003_bb0195","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1124\/mol.104.000893","article-title":"Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2","volume":"66","author":"Dilmac","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.634760","article-title":"Voltage-gated Ca(2+)-channel alpha1-subunit de novo missense mutations: gain or loss of function - implications for potential therapies","volume":"13","author":"Striessnig","year":"2021","journal-title":"Front Synaptic Neurosci."},{"issue":"2","key":"10.1016\/j.yjmcc.2022.10.003_bb0205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(24)35326-1","article-title":"Effects of the T-type ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue","volume":"292","author":"Benardeau","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yjmcc.2022.10.003_bb0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.yjmcc.2022.10.003_bb0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/pcad.2000.7010","article-title":"Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies","volume":"43","author":"Opie","year":"2000","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"5 Pt 1","key":"10.1016\/j.yjmcc.2022.10.003_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0895-7061(96)00508-0","article-title":"Calcium channel blockers for hypertension: dissecting the evidence for adverse effects","volume":"10","author":"Opie","year":"1997","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.yjmcc.2022.10.003_bb0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1874467208666150507105845","article-title":"Pharmacology of L-type calcium channels: novel drugs for old targets?","volume":"8","author":"Striessnig","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mehy.2006.05.070","article-title":"Revival of nifedipine, a dihydropyridine-based calcium blocker","volume":"68","author":"Yamagishi","year":"2007","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4196\/kjpp.2016.20.1.119","article-title":"Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization","volume":"20","author":"Lee","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.118.114025","article-title":"Mexiletine block of voltage-gated sodium channels: isoform- and state-dependent drug-pore interactions","volume":"95","author":"Nakagawa","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.yjmcc.2022.10.003_bb0245","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00424-020-02429-7","article-title":"Neuronal Cav3 channelopathies: recent progress and perspectives","volume":"472","author":"Lory","year":"2020","journal-title":"Pflugers Arch."},{"issue":"7","key":"10.1016\/j.yjmcc.2022.10.003_bb0250","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-020-02418-w","article-title":"De novo CACNA1D ca(2+) channelopathies: clinical phenotypes and molecular mechanism","volume":"472","author":"Ortner","year":"2020","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13229-019-0310-4","article-title":"Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder","volume":"11","author":"Hofer","year":"2020","journal-title":"Mol. Autism."},{"issue":"15","key":"10.1016\/j.yjmcc.2022.10.003_bb0260","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddx175","article-title":"New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy","volume":"26","author":"Pinggera","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0265","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0707414","article-title":"Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels","volume":"152","author":"Yarotskyy","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0270","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuropharm.2006.10.006","article-title":"Roscovitine differentially affects CaV2 and Kv channels by binding to the open state","volume":"52","author":"Buraei","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.yjmcc.2022.10.003_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1074\/jbc.M109.076448","article-title":"Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation","volume":"285","author":"Yarotskyy","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7337","key":"10.1016\/j.yjmcc.2022.10.003_bb0280","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09855","article-title":"Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome","volume":"471","author":"Yazawa","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yjmcc.2022.10.003_bb0285","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1113\/jphysiol.2008.161737","article-title":"The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation","volume":"587","author":"Yarotskyy","year":"2009","journal-title":"J. Physiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282822005363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282822005363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:37:53Z","timestamp":1758314273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282822005363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":57,"alternative-id":["S0022282822005363"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2022.10.003","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}